BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 9229325)

  • 21. A phase II study of weekly 24-hour infusion of high-dose 5-fluorouracil and leucovorin (HDFL) in the treatment of recurrent or metastatic colorectal cancers.
    Yeh KH; Cheng AL; Lin MT; Hong RL; Hsu CH; Lin JF; Chang KJ; Lee PH; Chen YC
    Anticancer Res; 1997; 17(5B):3867-71. PubMed ID: 9427794
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A phase II study of irinotecan with bi-weekly, low-dose leucovorin and bolus and continuous infusion 5-fluorouracil (modified FOLFIRI) as salvage therapy for patients with advanced or metastatic gastric cancer.
    Kim SG; Oh SY; Kwon HC; Lee S; Kim JH; Kim SH; Kim HJ
    Jpn J Clin Oncol; 2007 Oct; 37(10):744-9. PubMed ID: 17923456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 5-fluorouracil modulated by leucovorin, methotrexate and mitomycin: highly effective, low-cost chemotherapy for advanced colorectal cancer.
    Sobrero A; Guglielmi A; Cirillo M; Recaldin E; Frassineti GL; Aschele C; Ravaioli A; Testore P; Caroti C; Gallo L; Pessi MA; Cortesi E; Turci D; Grossi F; Labianca R
    Br J Cancer; 2001 Apr; 84(8):1023-8. PubMed ID: 11308248
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized phase II trial of 5-fluorouracil, with or without human interferon-beta, for advanced colorectal cancer.
    Villar-Grimalt A; Candel MT; Massuti B; Lizón J; Sánchez B; Frau A; Gorostidi B; Goedkoop R
    Br J Cancer; 1999 May; 80(5-6):786-91. PubMed ID: 10360656
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Weekly infusional high-dose 5-fluorouracil and leucovorin and biweekly cisplatin: a convenient treatment option in advanced gastric cancer.
    Kundel Y; Purim O; Figer A; Stemmer SM; Tichler T; Sulkes J; Sulkes A; Brenner B
    Med Sci Monit; 2008 Apr; 14(4):CR190-5. PubMed ID: 18376346
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of an irinotecan plus bolus 5-fluorouracil and L-leucovorin regimen for metastatic colorectal cancer in Japanese patients: experience in a single institution in Japan.
    Yoshino T; Boku N; Onozawa Y; Hironaka S; Fukutomi A; Yamaguchi Y; Hasuike N; Yamazaki K; Machida N; Ono H
    Jpn J Clin Oncol; 2007 Sep; 37(9):686-91. PubMed ID: 17720736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical effect and characteristics of low dose leucovorin and high dose 5-FU therapy in patients with recurrent gastric cancer--a new method of biochemical modulation].
    Kajiyama Y; Tsurumaru M; Ono Y; Udagawa H; Watanabe G; Suzuki M; Matsuda M; Akiyama H
    Gan To Kagaku Ryoho; 1993 Sep; 20(12):1797-801. PubMed ID: 8379672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The EORTC GI group experience with high-dose infusional 5-FU in colorectal cancer.
    Blijham GH
    J Infus Chemother; 1996; 6(3):114-7. PubMed ID: 9229320
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of the levogyre and dextro-levogyre forms of leucovorin in a phase III trial of bimonthly LV5FU2 versus monthly 5-fluorouracil and high-dose leucovorin for patients with stage II and III colon cancer (GERCOR C96.1).
    Baumgaertner I; Quinaux E; Khalil A; Louvet C; Buyse M; de Gramont A; André T;
    Clin Colorectal Cancer; 2010 Apr; 9(2):E5-10. PubMed ID: 20378497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Progress in development of chemotherapy of colorectal carcinoma].
    Köhne CH
    Med Klin (Munich); 1996 Apr; 91 Suppl 3():33-7. PubMed ID: 8692117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Randomized phase III study of high-dose fluorouracil given as a weekly 24-hour infusion with or without leucovorin versus bolus fluorouracil plus leucovorin in advanced colorectal cancer: European organization of Research and Treatment of Cancer Gastrointestinal Group Study 40952.
    Köhne CH; Wils J; Lorenz M; Schöffski P; Voigtmann R; Bokemeyer C; Lutz M; Kleeberg C; Ridwelski K; Souchon R; El-Serafi M; Weiss U; Burkhard O; Rückle H; Lichnitser M; Langenbuch T; Scheithauer W; Baron B; Couvreur ML; Schmoll HJ;
    J Clin Oncol; 2003 Oct; 21(20):3721-8. PubMed ID: 12963704
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Double modulation with methotrexate and L-leucovorin of weekly 24- hour fluorouracil infusion in fluorouracil-refractory colorectal cancer.
    Colleoni M; Nelli P; Vicario G; Pancheri F; Sgarbossa G; Manente P
    Anticancer Res; 1996; 16(5B):3101-4. PubMed ID: 8920775
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Late phase II trial of high-dose l-leucovorin and 5-fluorouracil in advanced colorectal carcinoma. l-Leucovorin and 5-FU Study Group (Japan Eastern Group)].
    Yoshino M; Ota K; Kurihara M; Akazawa S; Tominaga T; Sasaki T; Konishi T; Kodaira S; Kumai K; Sugano K
    Gan To Kagaku Ryoho; 1995 May; 22(6):785-92. PubMed ID: 7755386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relationship between 5-fluorouracil (5-FU) dose intensity and therapeutic response in patients with advanced colorectal cancer receiving infusional therapy containing 5-FU.
    Gamelin EC; Danquechin-Dorval EM; Dumesnil YF; Maillart PJ; Goudier MJ; Burtin PC; Delva RG; Lortholary AH; Gesta PH; Larra FG
    Cancer; 1996 Feb; 77(3):441-51. PubMed ID: 8630950
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of refractory ovarian cancer with 5-fluorouracil and leucovorin.
    Préfontaine M; Donovan JT; Powell JL; Buley L
    Gynecol Oncol; 1996 May; 61(2):249-52. PubMed ID: 8626142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A cooperative late phase II trial of l-leucovorin and 5-fluorouracil in the treatment of advanced gastric cancer. l-Leucovorin and 5-FU Study Group (Japan Western Group)].
    Takeda S; Taguchi T; Ohta J; Kurihara M; Abe T; Ohtani T; Yonemura Y; Ohno T; Hirabayashi N; Nakano S
    Gan To Kagaku Ryoho; 1995 Jun; 22(7):903-10. PubMed ID: 7793996
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The French experience with infusional 5-fluorouracil in advanced colorectal cancer.
    de Gramont A; Louvet C; Krulik M
    J Infus Chemother; 1996; 6(3):133-6. PubMed ID: 9229324
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Weekly high-dose leucovorin versus low-dose leucovorin combined with fluorouracil in advanced colorectal cancer: results of a randomized multicenter trial. Study Group for Palliative Treatment of Metastatic Colorectal Cancer Study Protocol 1.
    Jäger E; Heike M; Bernhard H; Klein O; Bernhard G; Lautz D; Michaelis J; Meyer zum Büschenfelde KH; Knuth A
    J Clin Oncol; 1996 Aug; 14(8):2274-9. PubMed ID: 8708717
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Clinical study of ambulatory cancer chemotherapy for advanced colorectal cancer].
    Takahashi N; Kunii Y; Ota K
    Gan To Kagaku Ryoho; 1995 Dec; 22 Suppl 4():447-52. PubMed ID: 8849291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinical evaluation of leucovorin and 5-fluorouracil].
    Sasaki T
    Gan To Kagaku Ryoho; 1995 Jul; 22(8):1001-8. PubMed ID: 7611750
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.